Not All Bacteria Are Equal — and Neither Are Probiotics
The pet probiotic market has expanded rapidly, generating a category of products where marketing far outpaces the evidence in most cases. Yet dismissing probiotics entirely on this basis would be a mistake. A narrower, more accurate position is that specific strains at specific doses have genuine clinical utility in defined situations — while many products on the shelf deliver neither the strains nor the doses required to produce any meaningful effect. Knowing the difference matters.
How the Gut Microbiome Works in Companion Animals
Dogs and cats each harbour a complex community of microorganisms in the gastrointestinal tract — bacteria, fungi, archaea, and viruses — collectively referred to as the gut microbiome. This community performs critical functions including short-chain fatty acid production, immune regulation, pathogen exclusion, and synthesis of certain B vitamins. Disruption of microbiome composition, termed dysbiosis, is associated with conditions ranging from acute diarrhoea and inflammatory bowel disease to atopic dermatitis and anxiety.
Probiotics introduce live microorganisms intended to confer health benefits by supplementing or modulating resident microbial populations. Whether they do so effectively depends almost entirely on strain selection, survivability through gastric acid, and dose.
Strains With Evidence in Dogs
Strain identification requires attention to genus, species, and strain designation — not genus alone. "Lactobacillus" is not a probiotic; a specific strain like Lactobacillus acidophilus DSM 13241 is.
Enterococcus faecium SF68
Among the best-studied strains in veterinary medicine, Enterococcus faecium SF68 has been evaluated in multiple controlled trials in dogs. Evidence supports reduced duration and severity of acute diarrhoea and improved stool consistency in dogs undergoing antibiotic treatment or dietary transition. It is one of very few strains with canine-specific trial data rather than extrapolation from human or rodent research.
Lactobacillus acidophilus and Lactobacillus rhamnosus
Both strains appear in canine studies with positive outcomes for acute gastrointestinal disturbance and post-antibiotic microbiome recovery. Lactobacillus rhamnosus GG, one of the most researched strains in human medicine, shows moderate colonisation in dogs but does contribute measurably to stool quality outcomes in some trials.
Bifidobacterium animalis AHC7
This strain, developed with companion animals specifically in mind, has canine trial data supporting reduced acute diarrhoea duration. It colonises the canine gut more reliably than many human-derived strains, which is a meaningful advantage given the species differences in intestinal environment.
Strains With Evidence in Cats
Feline microbiome research lags behind canine, but several strains have relevant data.
Enterococcus faecium SF68
As in dogs, this strain has demonstrated benefit in cats for managing acute diarrhoea and supporting microbiome recovery following antibiotic use. It is the most consistently supported strain across both species in peer-reviewed literature.
Lactobacillus acidophilus DSM 13241
Feline-specific trials support its use for reducing faecal odour, improving stool consistency, and supporting immune function. It is one of few strains with identified colonisation in the feline lower intestinal tract.
Multi-Strain Blends
Some veterinary products combine several strains with complementary mechanisms. Evidence for blends is less consistent than for individual characterised strains, but products containing clinically evaluated organisms at appropriate colony-forming unit (CFU) counts — typically between one billion and ten billion CFU per dose — are more likely to produce measurable outcomes than products listing uncharacterised strains at low counts.
When Probiotics Are Most Likely to Help
- Acute diarrhoea: The strongest evidence base. Probiotics can shorten episode duration and reduce severity, particularly when administered at onset.
- Antibiotic-associated gastrointestinal disturbance: Concurrent or immediate post-antibiotic use helps restore microbiome composition disrupted by broad-spectrum treatment.
- Dietary transition: Short-term supplementation during food changes supports gut adaptation and reduces loose stools.
- Stress-related gastrointestinal signs: Boarding, travel, or environmental change frequently triggers soft stools in cats and dogs. Probiotics initiated before stressful events have modest but documented benefit.
- Chronic gastrointestinal disease: Evidence here is more mixed. Probiotics can be a useful adjunct in inflammatory bowel disease management but are not a standalone treatment and should be part of a vet-supervised protocol.
When Probiotics Are Unlikely to Help
Probiotics are not appropriate primary treatment for vomiting of unknown origin, blood in stool, significant lethargy accompanying gastrointestinal signs, or suspected foreign body ingestion. These presentations require veterinary assessment first. Using probiotics to manage ongoing symptoms without identifying the underlying cause risks delaying necessary investigation.
Choosing a Product and Getting It Right
- Look for named strains with at least genus, species, and strain designation on the label — not simply "Lactobacillus blend."
- Confirm CFU count at end of shelf life, not at manufacture — many products lose viability before use.
- Choose products that have completed stability testing demonstrating survival through gastric acid.
- Store according to label guidance — many require refrigeration to maintain viability.
- Consult your vet before using probiotics in immunocompromised animals, very young animals, or those with serious systemic illness.